Theoretical and practical (clinical) considerations concerning proteolytic enzymes and their inhibitors with particular reference to changes in the plasminogen-plasmin system observed during assisted circulation in man.
D001243:Assisted Circulation; D001777:Blood Coagulation / Q000187:drug effects; D005112:Extracorporeal Circulation; D005340:Fibrinogen / Q000032:analysis; D005341:Fibrinolysin / Q000032:analysis*; D005342:Fibrinolysis / Q000187:drug effects; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D010447:Peptide Hydrolases / Q000494:pharmacology*; D010477:Perfusion; D010958:Plasminogen / Q000032:analysis*; D011437:Propylamines / Q000494:pharmacology; D011480:Protease Inhibitors; D012769:Shock; D013997:Time Factors
D011437:Propylamines; D011480:Protease Inhibitors; D005340:Fibrinogen; D010958:Plasminogen; D006493:Heparin; D010447:Peptide Hydrolases; D005341:Fibrinolysin